NOVEN ANNOUNCES 2004 EARNINGS RELEASE DATE

Back

Miami, FL, February 24, 2005 -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the scheduled release date of its 2004 financial results.

On March 15, before the market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter and year ended December 31, 2004. At 11:00 a.m. Eastern Time the same day, a conference call among management and analysts will be broadcast live via the Internet at www.noven.com, and thereafter a rebroadcast will be accessible at the same website. A taped replay of the call will be available beginning in the afternoon of March 15 through March 17 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering the account #286 and the conference ID #140929.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are sold in over 30 countries, and a range of new patches are being investigated and developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Back

Copyright ©  2005 Noven Pharmaceuticals, Inc. All rights reserved.